Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-21-000005

Chief Operating Officer sold 45,049 shares at an average $12.03 ($541,719)

  • Chief Operating Officer acquired 77,624 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shea Jacqueline Elizabeth · Chief Operating Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-27 Exercise or conversion : show line 1 in the form +22,376 $3.62 $81,001 34,296 D
2021-01-27 Sale : show line 2 in the form −22,376 $12.01 $268,736 11,920 D
2021-01-27 Sale : show line 3 in the form −5,960 $12.04 $71,758 5,960 D
2021-01-28 Exercise or conversion : show line 4 in the form +55,248 $3.62 $199,998 61,208 D
2021-01-28 Sale : show line 5 in the form −16,713 $12.04 $201,225 44,495 D
Open-market sales · 45,049 sh · avg $12.03 · $541,719

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-01-27 Exercise or conversion : show line 6 in the form Common Stock Option −22,376 177,624 D
2021-01-28 Exercise or conversion : show line 7 in the form Common Stock Option −55,248 122,376 D
Loading xslF345X03/wf-form4_161196497789987.xml…